Among the requirements is the one about registration of immunological medication in Ukraine. In order to confirm the registration, the participant must provide a verified copy of registration ID for the immunobiological medication.
The estimated price is roughly five million US dollars.
As is known, the U.S. will begin sharing 60 million doses of AstraZeneca COVID-19 vaccines with the world once it clears federal safety reviews. The Associated Press reported that, citing the White House. About 10 million doses of the AstraZeneca vaccine have been produced but have yet to pass a review by the FDA to “meet its expectations for product quality.” About 50 million more doses are in various stages of production and could be available to ship in May and June.